ADD TO CALENDARLOGIN TO ADD TO YOUR SCHEDULE

The opioid epidemic continues to pose an extraordinary challenge to all aspects of our society. This is most evident in the correctional setting, where a disproportionately high percentage of the population has opioid use disorder (OUD).
The Department of Justice (DOJ) in April 2022 announced the inclusion of OUD as a chronic disease in an amended section of the Americans with Disabilities Act (ADA). This change protects incarcerated patients with (OUD) from discrimination and increases their access to appropriate medical treatment through a MAT/MOUD program. In December 2022, the Office of the President signed the Consolidated Appropriations Act for 2023, which includes significant legislation to address the worsening overdose crisis. The passage and signing of the bill and its Mainstreaming Addiction Treatment (MAT) Act provision, removes federal barriers to medications for OUD, reduces stigma, and increases access to life-saving treatment that prevents overdoses and supports recovery.

PRESENTERS: Dr. Kaveh Ofogh, President & CEO, Mediko Inc

---

BACK
HOME